Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Glioma 3Wilms Tumor 2Sarcoma, Ewing 2Sarcoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Medulloblastoma 2Lymphoma, Non-Hodgkin 2Histiocytosis, Langerhans-Cell 2Hepatoblastoma 2Ependymoma 2Chondrosarcoma 2Xanthogranuloma, Juvenile 1Lymphoma, Follicular 1Histiocytic Sarcoma 1Cholangiocarcinoma 1Central Nervous System Neoplasms 1

Interventions

Cyclophosphamide 49fludarabine phosphate 37Peripheral Blood Stem Cell Transplantation 32Cyclosporine 30Mycophenolic Acid 29Busulfan 27Whole-Body Irradiation 25Radiotherapy 24Antilymphocyte Serum 24Filgrastim 23Melphalan 18Tacrolimus 16Methylprednisolone 15Cord Blood Stem Cell Transplantation 15Methotrexate 14Etoposide 12Thiotepa 8sargramostim 6Cytarabine 6Rituximab 5fludarabine 4aldesleukin 4Therapeutics 4Sirolimus 4Carmustine 4Biopsy 4thymoglobulin 3Polymerase Chain Reaction 3Paclitaxel 3Itraconazole 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Follicular × ivosidenib × Sarcoma × Clear all
NCT04278781 2026-04-23

AG-120 in People With IDH1 Mutant Chondrosarcoma

Memorial Sloan Kettering Cancer Center

Phase 2 Active not recruiting
6 enrolled
LymphoidSarcoma

Chondrosarcoma, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡